Lundbeckfond Ventures et al. invest in DySis Medical
Lundbeckfond Ventures has led a £7.4m fundraising round in DySis Medical Ltd, a women’s health medical devices company.
The investment is comprised of £6m from Copenhagen-based Lundbeckfond, an investment group specialising in life sciences.
A further £1.4m was raised through existing shareholders Albion Ventures, NBGI and the Scottish Investment Bank (SIB), the investment arm of Scottish Enterprise.
Company
Founded in 2002 and based near Edinburgh, DySis Medical develops and markets the DySis colposcope, which detects early stages of cervical cancer.
The system was recommended for procurement by the UK National Institute for Health and Clinical Excellence in August 2012.
The DySis colposcopy system has a CE mark and has been cleared for use by the US Food and Drugs Administration. With a growing installed base of instruments, an estimated 10,000 women have had a DySis exam to date.
People
Alastair Atkinson is the CEO of DySis. Mikael Strindlund and Casper Breum from Lundbeckfond will join the company's board.
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater